Aligned closely with the Kingdom’s Vision 2030 objectives, the SFDA has embedded digital transformation at the core of its pharmacovigilance and cosmetic safety systems, reinforcing trust, efficiency, and transparency across healthcare regulation.

One of the most significant milestones in this journey has been the modernization of the National Pharmacovigilance Centre’s adverse reaction reporting framework. The transition from paper-based reporting to the fully digital Saudi Vigilance platform marked a decisive shift toward data-driven health oversight.

Smart digital reporting forms, designed with structured data fields and behavioral prompts, have enhanced both the quality and completeness of safety reports. These improvements ensure that critical health information is captured accurately and consistently across the system.

Building on this digital foundation, the SFDA introduced centralized dashboards that allow real-time monitoring and analysis of adverse events. These dashboards help regulators identify early safety signals, spot under-reporting patterns, and respond proactively to emerging risks.

Automation has played a transformative role in strengthening medication safety operations. By introducing Robotic Process Automation, repetitive and time-consuming tasks such as report sorting, data validation, and signal identification are now handled efficiently by digital systems.

This shift has significantly reduced processing times while improving overall accuracy. At the same time, it has enhanced workplace productivity by allowing professionals to focus on higher-value analytical and decision-making responsibilities rather than routine manual work.

Digital innovation at the SFDA extends beyond monitoring and into prevention and education. The aRMMs e-learning platform has redefined how healthcare professionals are trained on high-risk medicines through engaging digital content and accessible learning tools.

By integrating safety alerts and educational materials directly into hospital information systems, the SFDA ensures that critical guidance reaches doctors and pharmacists at the point of care. This approach embeds safety into daily clinical workflows rather than treating it as a separate process.

Medication error prevention has also seen major advances through the launch of the Saudi Name Registration platform. This system replaces older tools with more sophisticated software capable of analyzing drug names in both Arabic and English.

Real-time alerts, automated updates, and advanced linguistic checks help detect potentially confusing medicine names before products enter the market. This proactive approach significantly reduces the risk of prescription and dispensing errors.

Looking ahead, the SFDA plans to extend these digital capabilities into cosmetic safety oversight. Artificial intelligence-driven tools are being developed to identify regulatory violations, automate ingredient checks, and analyze consumer feedback for early warning signals.

These initiatives demonstrate how technology can strengthen regulatory frameworks while keeping pace with fast-evolving product markets. By leveraging artificial intelligence, automation, and data analytics, the SFDA is shaping a forward-looking model for health and safety governance.

Beyond regulatory outcomes, these reforms support Saudi Arabia’s broader ambition to build a knowledge-based economy. Digital health systems contribute to workforce development, institutional efficiency, and innovation-driven growth across the healthcare sector.

Overall, the SFDA’s digital transformation highlights how strategic use of technology can enhance public trust, improve health outcomes, and position Saudi Arabia as a global reference point for modern, resilient, and future-ready health regulation.

The event, themed “Empowering Local Pharmaceutical Manufacturing: The Future of Generic Drugs in Saudi Arabia,” reflects the Kingdom’s growing commitment to health security and sustainable industry growth.

Set for Dec. 30, the conference aims to build a resilient and future-ready pharmaceutical sector that enhances public health and ensures a consistent supply of high-quality generic medications.

According to the organizers, the initiative supports national priorities focused on drug security, healthcare accessibility and strategic sector development.

The conference will serve as a dynamic platform that brings together healthcare experts, regulatory authorities, academic leaders, investors and major pharmaceutical manufacturers.

Its goal is to foster open dialogue, strengthen collaboration and align national and global best practices in generic drug production.

By uniting top minds from multiple sectors, the event will explore new developments in generic medicines, including scientific advancements, regulatory evolution and market opportunities.

Participants will address key challenges while identifying pathways for innovation, investment and policy improvement.

Interactive sessions, expert discussions and extensive networking opportunities will help broaden collaboration across the healthcare and pharmaceutical ecosystems.

This multi-stakeholder engagement is expected to support innovation, improve supply chain efficiency and enhance overall access to safe and effective generic medications.

The conference agenda includes strategic themes tailored to support long-term pharmaceutical growth and national health priorities.

Topics will include drug security strategies, investment incentives for local manufacturing, regulatory enablers and pharmaceutical research and development.

Discussions will also address formulation challenges, pricing and reimbursement frameworks, market access mechanisms, supply chain resilience and good manufacturing practice compliance.

These elements aim to reinforce public confidence in generics and promote a high standard of quality across all stages of production.

The event arrives at a transformative moment for Saudi Arabia’s healthcare and pharmaceutical sectors, fueled by Vision 2030’s focus on economic diversification and health sector modernization.

Local pharmaceutical production is increasingly recognized as a critical pillar of national drug security and economic resilience.

The growth of the generic drug industry plays an essential role in ensuring affordability, strengthening local capabilities and reducing dependency on imported medicines.

By advancing domestic manufacturing, the Kingdom enhances its readiness for future health challenges and positions itself as a regional leader in pharmaceutical innovation.

The conference is designed for key professionals involved in developing, regulating, producing and distributing generic and biosimilar medicines.

Its inclusive structure ensures that the collective expertise of regulators, scientists, industry leaders and healthcare providers can help shape a unified vision for the future.

Saudi Arabia’s commitment to building a sustainable pharmaceutical ecosystem supports wider national goals of health equity, innovation-driven growth and enhanced medical readiness.

As the industry evolves, the conference stands as a major step toward enabling a competitive, secure and future-focused pharmaceutical environment.

By fostering research, regulatory clarity and new investment opportunities, the event underscores the Kingdom’s determination to strengthen its pharmaceutical base and expand global partnerships.

The initiative reflects a positive outlook for the future of Saudi Arabia’s generic medicines sector, paving the way for a stronger, more resilient and more innovative healthcare system.

The event, held at the Riyadh Exhibition and Convention Center, was officially opened by Minister of Health Fahad Al-Jalajel.

Now in its eighth edition, the exhibition runs under the inspiring theme “Invest in Health,” bringing together visionaries, healthcare leaders, policymakers, and investors from across the world to explore the future of healthcare transformation.

Organized by the events company Tahaluf with the support of the Ministry of Health, the exhibition reflects Saudi Arabia’s commitment to advancing medical innovation, improving patient care, and fostering international collaboration in the health sector.

Over the years, the event has grown into one of the region’s most influential gatherings for the global health community, aligning perfectly with the Kingdom’s Vision 2030 objective of building a world-class healthcare system.

Minister Fahad Al-Jalajel expressed his pride in the event’s success and growing impact. “It is truly inspiring to witness how the Global Health Exhibition continues to expand each year,” he said.

“We are seeing remarkable growth not only in participation but also in partnerships and investments that are shaping the future of healthcare both locally and globally.”

He highlighted that in the previous edition, the exhibition generated SR55 billion ($14.66 billion) in investments. This year, partnerships and projects have already reached SR124 billion, with more expected as the exhibition continues.

In his opening remarks, the minister acknowledged the shared global challenges facing healthcare systems, including the increasing prevalence of chronic diseases, rising medical costs, and shortages in qualified healthcare professionals.

However, he emphasized that Saudi Arabia’s ongoing Health Transformation Program is effectively addressing these challenges through digital innovation, workforce development, and a strong focus on preventive care.

Al-Jalajel elaborated on how the Ministry of Health measures and maintains the quality of services in the Kingdom. “We assess healthcare quality through a wide range of indicators, including patient outcomes, satisfaction levels, and compliance with operational and health quality standards,” he explained.

“This data is continuously monitored through several specialized organizations such as the Facility Safety Program, the Saudi Patient Safety Center, the Council of Health Insurance, and the Saudi Health Council.”

These organizations ensure that healthcare practitioners, facilities, and medical equipment meet the highest safety and performance standards, often in coordination with the Saudi Food and Drug Authority.

The integrated approach highlights the Kingdom’s dedication to transparency, accountability, and excellence in healthcare delivery.

Among the most notable achievements announced during the event was Saudi Arabia’s success in reducing deaths from chronic diseases by 40 percent since 2017.

The country has also achieved a nearly 60 percent reduction in fatalities caused by traffic accidents since 2016, thanks to improved emergency response systems and awareness programs.

Furthermore, life expectancy in the Kingdom has risen significantly — from 74 years in 2016 to 79 years in 2025 — a clear reflection of better healthcare access and lifestyle changes encouraged by public health campaigns.

The exhibition also unveiled several groundbreaking initiatives designed to shape the next generation of healthcare services.

One of the most exciting developments is the AI Physician Experience, a digital innovation aimed at improving disease diagnosis and patient care through artificial intelligence.

The Ministry also announced plans for localizing vaccine manufacturing, in collaboration with leading global biopharmaceutical companies — a move that strengthens national health security and promotes self-sufficiency in medical production.

Another major highlight was the introduction of the Smart Health Coach, developed in partnership with Google through the Sehhaty application.

This digital platform combines AI-powered recommendations with personal health tracking, empowering individuals to take proactive steps toward better health.

The initiative aligns with the Kingdom’s broader digital transformation strategy, which aims to make healthcare more personalized, accessible, and efficient.

The Global Health Exhibition 2025 stands as a testament to Saudi Arabia’s unwavering commitment to building a healthier, more resilient society.

Through collaboration, innovation, and investment, the Kingdom continues to set new benchmarks in global healthcare excellence. As Minister Al-Jalajel emphasized, “Investing in health is not just about improving services — it is about investing in the future of humanity.”

Under the inspiring theme “Invest in Health,” the event brings together experts, innovators, and thought leaders from more than 130 countries to share ideas and showcase cutting-edge advancements shaping the medical world.

The Makkah Health Cluster’s participation is a reflection of Saudi Arabia’s commitment to healthcare transformation in alignment with Vision 2030.

This national vision emphasizes the modernization of healthcare systems, integration of advanced technologies, and creation of a sustainable health infrastructure that benefits citizens and residents alike.

The cluster’s innovative use of artificial intelligence stands as a powerful example of how smart technologies are making healthcare faster, more efficient, and more patient-centered.

One of the cluster’s most celebrated innovations at the exhibition is the iSelfie project, a revolutionary AI-based health assessment tool that utilizes photoplethysmography (PPG) technology.

This innovative approach allows for the rapid evaluation of a patient’s vital signs by simply analyzing facial features through a camera, making the process non-invasive, accurate, and highly efficient.

Traditionally, emergency departments required an average of seven minutes per patient assessment; however, with iSelfie, that time has been cut down to just two minutes.

This represents a 70 percent reduction in time, dramatically improving emergency department efficiency and patient flow.

The cluster’s efforts are not only focused on innovation but also on cost-efficiency and sustainability. Through the introduction of its smart vital signs project, Makkah Health Cluster plans to implement AI-powered solutions across 14 hospitals and 15 primary healthcare centers.

This initiative is expected to save SR120,000 ($32,000) annually by replacing traditional Dynamap devices with automated digital tools.

Beyond the financial savings, the initiative aims to enhance workflow management, allowing healthcare professionals to spend more time providing direct patient care instead of manual data collection and monitoring.

Moreover, this transformation has a significant impact on workforce optimization. By incorporating AI automation, the project is projected to reduce nursing costs by SR15.3 million annually and enhance operational efficiency by up to 50 percent, all while maintaining high-quality healthcare standards.

These advancements reflect how digital transformation is empowering healthcare institutions to deliver better outcomes with fewer resources, making healthcare more sustainable in the long run.

The integration of AI within healthcare is one of the core priorities of Vision 2030, which envisions a digitally advanced, patient-driven health system.

The innovations presented by Makkah Health Cluster directly support this mission by improving accessibility, enhancing diagnostic accuracy, and promoting self-care through technology.

These projects are reshaping how healthcare is delivered in Saudi Arabia—making it more proactive, predictive, and personalized.

The Global Health Exhibition serves as an essential platform for global collaboration, featuring over 100 dialogue sessions and workshops dedicated to the future of healthcare.

Topics range from artificial intelligence and biotechnology to health investments and sustainable medical practices.

Experts and participants from around the world are engaging in meaningful discussions about how AI can redefine patient care, streamline hospital management, and address pressing healthcare challenges across different regions.

Makkah Health Cluster’s participation highlights the Kingdom’s growing influence in global health innovation.

By sharing its pioneering projects and success stories, the cluster demonstrates how Saudi healthcare institutions are becoming models of excellence, blending innovation with compassion.

These initiatives underscore a collective vision—one that looks beyond traditional healthcare systems toward a smarter, healthier, and more connected future.

Ultimately, the Makkah Health Cluster’s showcase at the Riyadh expo reflects not only technological progress but also a deep commitment to improving lives.

Through AI-driven innovation, efficiency gains, and dedication to patient-centered care, the cluster is helping Saudi Arabia position itself as a global leader in digital health transformation, paving the way for a new era of accessible, intelligent, and sustainable healthcare solutions for all.

Now in its eighth edition, the event has become a cornerstone for the Kingdom’s efforts to attract investment, foster innovation, and advance the strategic goals of Vision 2030.

The exhibition, held with the support of the Ministry of Health, will highlight Saudi Arabia’s commitment to enhancing healthcare quality, boosting the sector’s contribution to the economy, and establishing the Kingdom as a global hub for healthcare innovation and manufacturing.

Over the next decade, the Saudi healthcare industry is projected to grow significantly, from SR199 billion ($53 billion) in 2020 to SR318 billion by 2030, with private sector contributions expected to double to SR145 billion.

The Ministry of Health has emphasized its focus on creating a competitive investment environment, streamlining regulatory processes, and supporting innovation across critical areas such as biotechnology, pharmaceuticals, vaccine production, health tourism, digital health solutions, and artificial intelligence in healthcare.

These initiatives are designed to accelerate progress toward a self-sufficient, innovation-driven healthcare ecosystem in the Kingdom.

The Global Health Exhibition serves as a vital platform for connecting local and international stakeholders, showcasing the latest medical technologies, and facilitating high-value collaborations.

Last year’s edition generated investments exceeding SR50 billion, including key deals such as the SR4 billion pharmaceutical partnership between NUPCO, Novo Nordisk, and Sanofi, the SR5 billion expansion plan by Fakeeh Care Group, and acquisitions worth over SR4 billion by Dallah Healthcare.

Building on this momentum, the 2025 exhibition is expected to announce new agreements and collaborations in biotechnology, advanced medical technologies, AI-driven healthcare solutions, and digital health platforms.

These developments are expected to further strengthen Saudi Arabia’s position as a regional leader in medical innovation, research, and development, attracting global expertise and investment to the Kingdom.

Experts highlight that the exhibition not only provides a showcase for cutting-edge technology and services but also demonstrates the Kingdom’s commitment to Vision 2030 goals of improving healthcare outcomes, supporting economic diversification, and encouraging private sector growth.

By fostering partnerships in pharmaceuticals, biotech, and healthcare technologies, Saudi Arabia aims to reduce dependency on imports, enhance local manufacturing capabilities, and stimulate job creation in high-value sectors.

The Ministry of Health has also emphasized the role of the exhibition in promoting sustainable growth and innovation, particularly in fields like vaccine production, biotechnology research, digital health solutions, and AI-enabled healthcare tools.

These areas are expected to be central to the Kingdom’s long-term strategy of establishing a world-class healthcare ecosystem that combines technological innovation with high-quality patient care.

Stakeholders anticipate that the event will attract international investors, leading global healthcare companies, and innovative startups, creating opportunities for knowledge exchange, joint ventures, and technology transfer.

The exhibition is expected to highlight Saudi Arabia’s readiness to lead in medical research, biotechnology, and advanced healthcare solutions, reinforcing its role as a hub for global healthcare innovation.

As the Kingdom continues to implement initiatives aligned with Vision 2030, the Global Health Exhibition 2025 represents a critical platform for showcasing achievements, facilitating investment, and strengthening partnerships across the healthcare sector.

By leveraging new technologies, fostering collaboration, and expanding strategic partnerships, Saudi Arabia is well-positioned to enhance healthcare access, improve quality, and secure long-term sustainable growth.

In summary, the upcoming exhibition is set to be a landmark event for Saudi Arabia’s healthcare sector, underlining the Kingdom’s dedication to innovation, investment, and international collaboration.

The announcements and partnerships expected at the event will pave the way for a robust, self-sufficient, and technologically advanced healthcare ecosystem, reflecting Saudi Arabia’s ambition to lead in global healthcare innovation.